The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice
- PMID: 19088255
- DOI: 10.1152/ajpendo.90691.2008
The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice
Abstract
In vitro studies suggest that the membrane G protein-coupled receptor GPR30 is a functional estrogen receptor (ER). The aim of the present study was to determine the possible in vivo role of GPR30 as a functional ER primarily for the regulation of skeletal parameters, including bone mass and longitudinal bone growth, but also for some other well-known estrogen-regulated parameters, including uterine weight, thymus weight, and fat mass. Three-month-old ovariectomized (OVX) GPR30-deficient mice (GPR30(-/-)) and wild-type (WT) mice were treated with either vehicle or increasing doses of estradiol (E(2); 0, 30, 70, 160, or 830 ng.mouse(-1).day(-1)). Body composition [bone mineral density (BMD), fat mass, and lean mass] was analyzed by dual-energy-X ray absorptiometry, while the cortical and trabecular bone compartments were analyzed by peripheral quantitative computerized tomography. Quantitative histological analyses were performed in the distal femur growth plate. Bone marrow cellularity and distribution were analyzed using a fluorescence-activated cell sorter. The estrogenic responses on most of the investigated parameters, including increase in bone mass (total body BMD, spine BMD, trabecular BMD, and cortical bone thickness), increase in uterine weight, thymic atrophy, fat mass reduction, and increase in bone marrow cellularity, were similar for all of the investigated E(2) doses in WT and GPR30(-/-) mice. On the other hand, E(2) treatment reduced longitudinal bone growth, reflected by decreased femur length and distal femur growth plate height, in the WT mice but not in the GPR30(-/-) mice compared with vehicle-treated mice. These in vivo findings demonstrate that GPR30 is not required for normal estrogenic responses on several major well-known estrogen-regulated parameters. In contrast, GPR30 is required for a normal estrogenic response in the growth plate.
Similar articles
-
GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.J Bone Miner Res. 2011 Feb;26(2):298-307. doi: 10.1002/jbmr.209. J Bone Miner Res. 2011. PMID: 20734455 Free PMC article.
-
Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6288-93. doi: 10.1073/pnas.1100454108. Epub 2011 Mar 28. Proc Natl Acad Sci U S A. 2011. PMID: 21444817 Free PMC article.
-
Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice.J Clin Invest. 1999 Oct;104(7):895-901. doi: 10.1172/JCI6730. J Clin Invest. 1999. PMID: 10510330 Free PMC article.
-
Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.Endocrinology. 1995 Jun;136(6):2435-41. doi: 10.1210/endo.136.6.7750465. Endocrinology. 1995. PMID: 7750465
-
The role of estrogens for male bone health.Eur J Endocrinol. 2009 Jun;160(6):883-9. doi: 10.1530/EJE-09-0118. Epub 2009 Mar 20. Eur J Endocrinol. 2009. PMID: 19304870 Review.
Cited by 45 articles
-
Rutin promotes osteogenic differentiation of periodontal ligament stem cells through the GPR30-mediated PI3K/AKT/mTOR signaling pathway.Exp Biol Med (Maywood). 2020 Mar;245(6):552-561. doi: 10.1177/1535370220903463. Epub 2020 Feb 9. Exp Biol Med (Maywood). 2020. PMID: 32036685
-
Effects of the selective GPER1 agonist G1 on bone growth.Endocr Connect. 2019 Sep;8(9):1302-1309. doi: 10.1530/EC-19-0274. Endocr Connect. 2019. PMID: 31434056 Free PMC article.
-
Estrogen receptor alpha differentially modulates host immunity in the bladder and kidney in response to urinary tract infection.Am J Clin Exp Urol. 2019 Jun 15;7(3):110-122. eCollection 2019. Am J Clin Exp Urol. 2019. PMID: 31317051 Free PMC article.
-
Rapid Aldosterone-Mediated Signaling in the DCT Increases Activity of the Thiazide-Sensitive NaCl Cotransporter.J Am Soc Nephrol. 2019 Aug;30(8):1454-1470. doi: 10.1681/ASN.2018101025. Epub 2019 Jun 28. J Am Soc Nephrol. 2019. PMID: 31253651 Free PMC article.
-
Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.Sci Rep. 2019 May 6;9(1):6991. doi: 10.1038/s41598-019-43518-7. Sci Rep. 2019. PMID: 31061445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Molecular Biology Databases
-
Research Materials